William Blair Initiates Coverage On Aardvark Therapeutics with Outperform Rating

Benzinga · 1d ago
William Blair analyst Andy Hsieh initiates coverage on Aardvark Therapeutics (NASDAQ:AARD) with a Outperform rating.